These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 33687982)
1. Achieving greater independence from commercial influence in research. Lexchin J; Bero LA; Davis C; Gagnon MA BMJ; 2021 Mar; 372():n370. PubMed ID: 33687982 [No Abstract] [Full Text] [Related]
2. Managing Conflicts of Interest in Industry-Sponsored Clinical Research: More Physician Engagement Is Required. Waldstreicher J; Johns ME JAMA; 2017 May; 317(17):1751-1752. PubMed ID: 28464168 [No Abstract] [Full Text] [Related]
3. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward. Samson K Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337 [No Abstract] [Full Text] [Related]
4. Implications of pharmaceutical industry funding on clinical research. Lexchin JR Ann Pharmacother; 2005 Jan; 39(1):194-7. PubMed ID: 15562137 [TBL] [Abstract][Full Text] [Related]
5. Institutional policy on financial conflict of interest: objectivity in research. Shalev M Lab Anim (NY); 2003 Apr; 32(4):16-7. PubMed ID: 19753745 [No Abstract] [Full Text] [Related]
6. Industry sponsorship in research and publishing: who is really to blame for perceived bias? Amsden GW Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974 [No Abstract] [Full Text] [Related]
7. Conflicting interests: the evolution of an issue. Healy D Monash Bioeth Rev; 2004 Oct; 23(4):8-18. PubMed ID: 15688509 [TBL] [Abstract][Full Text] [Related]
8. Research interactions between industry and academia: a corporate perspective. Citron P Physiologist; 1996 Jun; 39(3):81, 90-2. PubMed ID: 16764116 [No Abstract] [Full Text] [Related]
9. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review. Tereskerz PM Account Res; 2003; 10(3):137-58. PubMed ID: 14979317 [No Abstract] [Full Text] [Related]
10. [Conflicts of interest--an evidence-based approach]. Slørdal L; Eggen AE; Rygnestad T Tidsskr Nor Laegeforen; 2012 Jun; 132(11):1358-60. PubMed ID: 22717864 [No Abstract] [Full Text] [Related]
11. The impact of selective publication on clinical research in pain. Rowbotham MC Pain; 2008 Dec; 140(3):401-404. PubMed ID: 19004556 [No Abstract] [Full Text] [Related]
13. Independent medical research. van der Meer JW; de Gier AM; van Swaaij WP; Katan MB Neth J Med; 2007 Apr; 65(4):124-6. PubMed ID: 17452759 [No Abstract] [Full Text] [Related]
14. Drug research: marketing before evidence, sales before safety. Klemperer D Dtsch Arztebl Int; 2010 Apr; 107(16):277-8. PubMed ID: 20467552 [No Abstract] [Full Text] [Related]
15. Attitudes and behavior of privately-funded biomedical scientists. Krimsky S Account Res; 2009; 16(2):75-7. PubMed ID: 19353386 [No Abstract] [Full Text] [Related]
16. Practical and political problems with a global research tax. Resnik DB Am J Bioeth; 2010 Jun; 10(6):44-5. PubMed ID: 20526971 [No Abstract] [Full Text] [Related]
17. Human rights: the normative engine of fairness and research in developing countries. McMillan J Am J Bioeth; 2010 Jun; 10(6):47-9. PubMed ID: 20526973 [No Abstract] [Full Text] [Related]
18. Academic freedom and academic-industry relationships in biotechnology. Streiffer R Kennedy Inst Ethics J; 2006 Jun; 16(2):129-49. PubMed ID: 17036444 [TBL] [Abstract][Full Text] [Related]
19. The perverse consequences of a proposed global tax on research. MacDonald C; Walton N Am J Bioeth; 2010 Jun; 10(6):46-7. PubMed ID: 20526972 [No Abstract] [Full Text] [Related]
20. [The difficult relationship of industry and science. Money versus research]. Wessling A Pflege Z; 2011 Aug; 64(8):454-5. PubMed ID: 21882617 [No Abstract] [Full Text] [Related] [Next] [New Search]